Teva Appeals Win For Pfizer In Detrol Patent Suit

Law360, New York (February 18, 2010, 5:16 PM EST) -- Teva Pharmaceuticals USA Inc. is appealing its loss to Pfizer Inc. in a patent infringement suit over Detrol, taking issue with a federal judge's ruling that the generics maker failed to show Pfizer's patent for the bladder control drug was invalid and not enforceable

Teva and it subsidiary Ivax Pharmaceuticals Inc. filed a notice of appeal Wednesday in the U.S. District Court for the District of New Jersey, a day after Judge Dennis M. Cavanaugh issued final judgment for Pfizer.

The generics makers intend to ask...
To view the full article, register now.